Gastric schwannoma is a rare benign mesenchymal tumor originating from Schwann cells (nerve sheath cells) in the gastric wall. It accounts for 2-4% of all gastric mesenchymal tumors. Typically originates from the myenteric (Auerbach) plexus located in the muscularis propria layer. Histologically S-100 positive and CD117 (c-kit) and CD34 negative — a critical feature distinguishing from GIST. Most commonly seen between ages 40-60 with approximately equal gender distribution. Usually asymptomatic and incidentally discovered; ulceration and GI bleeding may occur with larger tumors. On CT, it appears as a homogeneously enhancing, submucosal origin, well-defined intramural mass. Malignant transformation is extremely rare.
Age Range
35-75
Peak Age
55
Gender
Female predominant
Prevalence
Rare
Gastric schwannoma originates from Schwann cells of the myenteric (Auerbach) plexus within the GI wall. These cells are glial cells forming the myelin sheath of peripheral nerves. The tumor develops through clonal proliferation of Schwann cells — unlike GIST, it originates from nerve sheath cells rather than interstitial cells of Cajal. S-100 protein is a specific marker of Schwann cells and is diffusely positive immunohistochemically; negativity for KIT (CD117) and CD34 is the key criterion distinguishing from GIST. The tumor typically grows intramurally within the muscularis propria with intact mucosal surface — showing endoluminal or exophytic growth pattern. The homogeneous cellular structure causes homogeneous enhancement on CT and homogeneous T2 hyperintensity on MRI. Characteristically, the tumor is surrounded by a peripheral lymphoid cuff — a histological hallmark that does not affect imaging findings but is important for pathological diagnosis. Malignant transformation is extremely rare, resulting in a predominantly benign course.
A homogeneously enhancing intramural gastric mass originating from the muscularis propria on CT — the homogeneous structure without necrosis/hemorrhage unlike GIST strongly suggests schwannoma. Definitive differentiation requires immunohistochemistry (S-100+, CD117/CD34-).
Well-defined, round or oval, homogeneously enhancing intramural mass originating from the muscularis propria on portal venous phase. Size typically ranges from 2-8 cm. Enhancement is homogeneous and moderate (50-80 HU increase). The mucosal surface is intact, although endoluminal or exophytic growth may be seen in large tumors. Necrosis, calcification, and hemorrhage are rare — distinguishing features from GIST.
Report Sentence
A well-defined, homogeneously enhancing ___ cm intramural mass originating from the muscularis propria in the gastric wall is observed, with gastric schwannoma as the leading consideration.
Moderate homogeneous enhancement in the arterial phase. Tends to be less hypervascular than GIST. Enhancement is homogeneous without necrotic or non-enhancing areas within the mass. Feeding vessels may be visible in tumors with exophytic growth pattern.
Report Sentence
The mass demonstrates moderate homogeneous enhancement in the arterial phase without significant hypervascularity or necrotic areas.
Homogeneous hyperintensity on T2-weighted images. Signal intensity is markedly higher than muscle tissue. The homogeneity reflects the uniform cellular structure of schwannomas and absence of necrosis/hemorrhage. The peripheral lymphoid cuff may sometimes appear as a thin hypointense rim, although this is not always appreciated. T2 hyperintensity is homogeneous throughout the tumor including any exophytic component.
Report Sentence
The mass demonstrates homogeneous hyperintense signal on T2-weighted MRI without heterogeneity suggestive of necrosis or hemorrhage, consistent with gastric schwannoma.
The mass shows iso- to hypointense signal relative to muscle on T1-weighted images. Homogeneous moderate enhancement after contrast administration. No T1 hyperintensity due to absence of intratumoral hemorrhage or fat content. Homogeneous enhancement pattern on post-contrast T1 is typical for schwannoma.
Report Sentence
The mass shows iso- to hypointense signal relative to muscle on T1-weighted images with homogeneous enhancement on post-contrast sequences.
Homogeneous hypoechoic, well-defined, round or oval intramural mass originating from the muscularis propria layer on ultrasound. The mucosal layer is intact, appearing as a thin hyperechoic line overlying the mass. Posterior acoustic enhancement (through-transmission) may be seen — despite the solid nature, this finding reflects the tumor's homogeneous cellular composition. Mild vascular flow may be seen on Doppler.
Report Sentence
A homogeneous hypoechoic, well-defined intramural mass originating from the muscularis propria with intact mucosal layer is observed in the gastric wall on ultrasound.
Mild to moderate diffusion restriction on diffusion-weighted imaging. ADC values are intermediate — higher than malignant tumors, lower than normal tissue. This finding reflects the moderate cellularity of schwannomas.
Report Sentence
Mild diffusion restriction is observed in the mass on diffusion-weighted imaging with intermediate ADC values, consistent with a benign mesenchymal tumor.
Criteria
Most common form. Well-defined, encapsulated, intramural mass. Mixture of Antoni A and Antoni B areas. S-100 diffusely positive. Peripheral lymphoid cuff present.
Distinct Features
Homogeneous enhancement, homogeneous T2 hyperintensity, no necrosis or hemorrhage. Size usually 2-5 cm. Predominantly benign course.
Criteria
Tumor shows exophytic growth from muscularis propria toward the serosa. Component projecting into the peritoneal cavity present. Same histological and immunohistochemical features.
Distinct Features
Exophytic component grows outward from the gastric wall on CT. Connection of the intramural component with the gastric wall is visible (bridging sign). May be confused with exophytic form of GIST — homogeneity supports schwannoma.
Criteria
Schwannoma larger than 5 cm. Rare with more challenging differential diagnosis from GIST. Benign biological behavior persists.
Distinct Features
Despite large size, homogeneity is generally preserved — unlike GIST, necrosis and hemorrhage are very rare. Ulceration and GI bleeding more common. Surgical resection recommended.
Distinguishing Feature
GIST tends to show heterogeneous enhancement with necrosis and hemorrhage (especially >5 cm), while schwannoma enhances homogeneously. GIST is CD117(+)/CD34(+), schwannoma is S-100(+)/CD117(-). Ulceration and cavitation are more common in GIST.
Distinguishing Feature
Leiomyoma shows iso- to hypointense signal on T2 similar to muscle, while schwannoma is T2 hyperintense. Leiomyoma is desmin(+)/SMA(+)/S-100(-), schwannoma is S-100(+)/desmin(-). Both enhance homogeneously but T2 signal difference is discriminating.
Distinguishing Feature
Carcinoid tumor is hypervascular with pronounced arterial phase enhancement; schwannoma shows moderate enhancement. Carcinoids are generally smaller (<2 cm) and may be multiple (type 1). Carcinoid is chromogranin A(+)/synaptophysin(+), schwannoma is S-100(+).
Distinguishing Feature
Lipoma shows pathognomonic fat density (-70 to -130 HU) on CT without enhancement; schwannoma is soft tissue density with enhancement. On MRI, lipoma is T1 hyperintense with signal loss on fat suppression; schwannoma is T1 iso- to hypointense.
Urgency
routineManagement
surgicalBiopsy
NeededFollow-up
12-monthGastric schwannoma is a benign tumor with extremely rare malignant transformation. Definitive preoperative differentiation from GIST is not possible by imaging alone — immunohistochemical confirmation (S-100+, CD117-) is required. EUS-guided biopsy or surgical resection provides both diagnosis and treatment. Surgical resection is curative with very low recurrence rate. EUS surveillance is an option for small, asymptomatic tumors.
Gastric schwannoma is a benign tumor with extremely rare malignant transformation. Differentiation from GIST is clinically important as imatinib therapy is not needed. Surgical resection is curative in symptomatic cases.